Literature DB >> 19580815

Nucleic acid binding activity of human Cockayne syndrome B protein and identification of Ca(2+) as a novel metal cofactor.

Brian R Berquist1, David M Wilson.   

Abstract

The Cockayne syndrome group B protein (CSB) is a member of the SWI/SNF2 subgroup of Superfamily 2 ATPases/nucleic acid translocases/helicases and is defective in the autosomal recessive segmental progeroid disorder Cockayne syndrome. This study examines the ATP-dependent and the ATP-independent biochemical functions of human CSB. We show that Ca(2+) is a novel metal cofactor of CSB for ATP hydrolysis, mainly through the enhancement of k(cat), and that a variety of biologically relevant model nucleic acid substrates can function to activate CSB ATPase activity with either Mg(2+) or Ca(2+) present. However, CSB lacked detectable ATP-dependent helicase and single- or double-stranded nucleic acid translocase activities in the presence of either divalent metal. CSB was found to support ATP-independent complementary strand annealing of DNA/DNA, DNA/RNA, and RNA/RNA duplexes, with Ca(2+) again promoting optimal activity. CSB formed a stable protein:DNA complex with a 34mer double-stranded DNA in electrophoretic mobility-shift assays, independent of divalent metal or nucleotide (e.g. ATP). Moreover, CSB was able to form a stable complex with a range of nucleic acid substrates, including bubble and "pseudo-triplex" double-stranded DNAs that resemble replication and transcription intermediates, as well as forked duplexes of DNA/DNA, DNA/RNA, and RNA/RNA composition, the latter two of which do not promote CSB ATPase activity. Association of CSB with DNA, independent of ATP binding or hydrolysis, was seemingly sufficient to displace or rearrange a stable pre-bound protein:DNA complex, a property potentially important for its roles in transcription and DNA repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19580815      PMCID: PMC2728148          DOI: 10.1016/j.jmb.2009.06.078

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  63 in total

1.  CSB is a component of RNA pol I transcription.

Authors:  John Bradsher; Jerome Auriol; Luca Proietti de Santis; Sebastian Iben; Jean Luc Vonesch; Ingrid Grummt; Jean Marc Egly
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

2.  Molecular characterization of an acidic region deletion mutant of Cockayne syndrome group B protein.

Authors:  M Sunesen; R R Selzer; R M Brosh; A S Balajee; T Stevnsner; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Chromatin remodeling by RSC involves ATP-dependent DNA translocation.

Authors:  Anjanabha Saha; Jacqueline Wittmeyer; Bradley R Cairns
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

4.  Manitoba aboriginal kindred with original cerebro-oculo- facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene.

Authors:  L B Meira; J M Graham; C R Greenberg; D B Busch; A T Doughty; D W Ziffer; D M Coleman; I Savre-Train; E C Friedberg
Journal:  Am J Hum Genet       Date:  2000-03-15       Impact factor: 11.025

5.  The ATPase domain but not the acidic region of Cockayne syndrome group B gene product is essential for DNA repair.

Authors:  R M Brosh; A S Balajee; R R Selzer; M Sunesen; L Proietti De Santis; V A Bohr
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

6.  Phenotypic consequences of mutations in the conserved motifs of the putative helicase domain of the human Cockayne syndrome group B gene.

Authors:  Meltem Muftuoglu; Rebecca Selzer; Jingsheng Tuo; Robert M Brosh; Vilhelm A Bohr
Journal:  Gene       Date:  2002-01-23       Impact factor: 3.688

7.  ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor.

Authors:  E Citterio; V Van Den Boom; G Schnitzler; R Kanaar; E Bonte; R E Kingston; J H Hoeijmakers; W Vermeulen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  XAB2, a novel tetratricopeptide repeat protein involved in transcription-coupled DNA repair and transcription.

Authors:  Y Nakatsu; H Asahina; E Citterio; S Rademakers; W Vermeulen; S Kamiuchi; J P Yeo; M C Khaw; M Saijo; N Kodo; T Matsuda; J H Hoeijmakers; K Tanaka
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

9.  The Cockayne Syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA.

Authors:  J Tuo; M Müftüoglu; C Chen; P Jaruga; R R Selzer; R M Brosh; H Rodriguez; M Dizdaroglu; V A Bohr
Journal:  J Biol Chem       Date:  2001-10-01       Impact factor: 5.157

10.  Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum.

Authors:  S Colella; T Nardo; E Botta; A R Lehmann; M Stefanini
Journal:  Hum Mol Genet       Date:  2000-05-01       Impact factor: 6.150

View more
  12 in total

Review 1.  Mitochondrial deficiency in Cockayne syndrome.

Authors:  Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2013-02-19       Impact factor: 5.432

2.  Cockayne Syndrome group B protein stimulates NEIL2 DNA glycosylase activity.

Authors:  Maria D Aamann; Christina Hvitby; Venkateswarlu Popuri; Meltem Muftuoglu; Lasse Lemminger; Cecilie K Skeby; Guido Keijzers; Byungchan Ahn; Magnar Bjørås; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Mech Ageing Dev       Date:  2014-01-07       Impact factor: 5.432

Review 3.  Cockayne syndrome: Clinical features, model systems and pathways.

Authors:  Ajoy C Karikkineth; Morten Scheibye-Knudsen; Elayne Fivenson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2016-08-06       Impact factor: 10.895

4.  A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.

Authors:  Morten Scheibye-Knudsen; Sarah J Mitchell; Evandro F Fang; Teruaki Iyama; Theresa Ward; James Wang; Christopher A Dunn; Nagendra Singh; Sebastian Veith; Md Mahdi Hasan-Olive; Aswin Mangerich; Mark A Wilson; Mark P Mattson; Linda H Bergersen; Victoria C Cogger; Alessandra Warren; David G Le Couteur; Ruin Moaddel; David M Wilson; Deborah L Croteau; Rafael de Cabo; Vilhelm A Bohr
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

Review 5.  Structure, function and regulation of CSB: a multi-talented gymnast.

Authors:  Robert J Lake; Hua-Ying Fan
Journal:  Mech Ageing Dev       Date:  2013-02-16       Impact factor: 5.432

6.  LEO1 is a partner for Cockayne syndrome protein B (CSB) in response to transcription-blocking DNA damage.

Authors:  Vinod Tiwari; Tomasz Kulikowicz; David M Wilson; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

7.  Enzymatic activities and DNA substrate specificity of Mycobacterium tuberculosis DNA helicase XPB.

Authors:  Seetha V Balasingham; Ephrem Debebe Zegeye; Håvard Homberset; Marie L Rossi; Jon K Laerdahl; Vilhelm A Bohr; Tone Tønjum
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy.

Authors:  Morten Scheibye-Knudsen; Mahesh Ramamoorthy; Peter Sykora; Scott Maynard; Ping-Chang Lin; Robin K Minor; David M Wilson; Marcus Cooper; Richard Spencer; Rafael de Cabo; Deborah L Croteau; Vilhelm A Bohr
Journal:  J Exp Med       Date:  2012-04-02       Impact factor: 14.307

9.  Human Cockayne syndrome B protein reciprocally communicates with mitochondrial proteins and promotes transcriptional elongation.

Authors:  Brian R Berquist; Chandrika Canugovi; Peter Sykora; David M Wilson; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2012-06-28       Impact factor: 16.971

10.  CSB interacts with SNM1A and promotes DNA interstrand crosslink processing.

Authors:  Teruaki Iyama; Sook Y Lee; Brian R Berquist; Opher Gileadi; Vilhelm A Bohr; Michael M Seidman; Peter J McHugh; David M Wilson
Journal:  Nucleic Acids Res       Date:  2014-12-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.